Series C+ · Biotech
Nuclera: Series C+
Provides rapid access to functional proteins through benchtop eProtein Discovery System
Funding history
Series C+ · This round$12M
Loading rounds…
Provides rapid access to functional proteins through benchtop eProtein Discovery System